167 related articles for article (PubMed ID: 19700330)
1. Synthesis, structure-affinity relationships, and modeling of AMDA analogs at 5-HT2A and H1 receptors: structural factors contributing to selectivity.
Shah JR; Mosier PD; Roth BL; Kellogg GE; Westkaemper RB
Bioorg Med Chem; 2009 Sep; 17(18):6496-504. PubMed ID: 19700330
[TBL] [Abstract][Full Text] [Related]
2. Potential modes of interaction of 9-aminomethyl-9,10-dihydroanthracene (AMDA) derivatives with the 5-HT2A receptor: a ligand structure-affinity relationship, receptor mutagenesis and receptor modeling investigation.
Runyon SP; Mosier PD; Roth BL; Glennon RA; Westkaemper RB
J Med Chem; 2008 Nov; 51(21):6808-28. PubMed ID: 18847250
[TBL] [Abstract][Full Text] [Related]
3. 9-Aminomethyl-9,10-dihydroanthracene (AMDA) analogs as structural probes for steric tolerance in 5-HT2A and H1 receptor binding sites.
Shah JR; Mosier PD; Peddi S; Roth BL; Westkaemper RB
Bioorg Med Chem Lett; 2010 Feb; 20(3):935-8. PubMed ID: 20045641
[TBL] [Abstract][Full Text] [Related]
4. Geometry-affinity relationships of the selective serotonin receptor ligand 9-(aminomethyl)-9,10-dihydroanthracene.
Runyon SP; Peddi S; Savage JE; Roth BL; Glennon RA; Westkaemper RB
J Med Chem; 2002 Apr; 45(8):1656-64. PubMed ID: 11931619
[TBL] [Abstract][Full Text] [Related]
5. Methoxy-substituted 9-aminomethyl-9,10-dihydroanthracene (AMDA) derivatives exhibit differential binding affinities at the 5-HT(2A) receptor.
Dewkar GK; Peddi S; Mosier PD; Roth BL; Westkaemper RB
Bioorg Med Chem Lett; 2008 Oct; 18(19):5268-71. PubMed ID: 18774714
[TBL] [Abstract][Full Text] [Related]
6. Spiro[9,10-dihydroanthracene]-9,3'-pyrrolidine-a structurally unique tetracyclic 5-HT2A receptor antagonist.
Peddi S; Roth BL; Glennon RA; Westkaemper RB
Eur J Pharmacol; 2003 Dec; 482(1-3):335-7. PubMed ID: 14660041
[TBL] [Abstract][Full Text] [Related]
7. Application of ligand SAR, receptor modeling and receptor mutagenesis to the discovery and development of a new class of 5-HT(2A) ligands.
Westkaemper RB; Glennon RA
Curr Top Med Chem; 2002 Jun; 2(6):575-98. PubMed ID: 12052195
[TBL] [Abstract][Full Text] [Related]
8. 9-(Aminomethyl)-9,10-dihydroanthracene is a novel and unlikely 5-HT2A receptor antagonist.
Westkaemper RB; Runyon SP; Bondarev ML; Savage JE; Roth BL; Glennon RA
Eur J Pharmacol; 1999 Sep; 380(1):R5-7. PubMed ID: 10513561
[TBL] [Abstract][Full Text] [Related]
9. Influence of chain length and N-alkylation on the selective serotonin receptor ligand 9-(aminomethyl)-9,10-dihydroanthracene.
Runyon SP; Savage JE; Taroua M; Roth BL; Glennon RA; Westkaemper RB
Bioorg Med Chem Lett; 2001 Mar; 11(5):655-8. PubMed ID: 11266163
[TBL] [Abstract][Full Text] [Related]
10. Molecular modeling and docking studies of human 5-hydroxytryptamine 2A (5-HT2A) receptor for the identification of hotspots for ligand binding.
Kanagarajadurai K; Malini M; Bhattacharya A; Panicker MM; Sowdhamini R
Mol Biosyst; 2009 Dec; 5(12):1877-88. PubMed ID: 19763327
[TBL] [Abstract][Full Text] [Related]
11. New serotonin 5-HT(2A), 5-HT(2B), and 5-HT(2C) receptor antagonists: synthesis, pharmacology, 3D-QSAR, and molecular modeling of (aminoalkyl)benzo and heterocycloalkanones.
Brea J; Rodrigo J; Carrieri A; Sanz F; Cadavid MI; Enguix MJ; Villazón M; Mengod G; Caro Y; Masaguer CF; Raviña E; Centeno NB; Carotti A; Loza MI
J Med Chem; 2002 Jan; 45(1):54-71. PubMed ID: 11754579
[TBL] [Abstract][Full Text] [Related]
12. Exploring the relationship between binding modes of 9-(aminomethyl)-9,10-dihydroanthracene and cyproheptadine analogues at the 5-HT2A serotonin receptor.
Westkaemper RB; Runyon SP; Savage JE; Roth BL; Glennon RA
Bioorg Med Chem Lett; 2001 Feb; 11(4):563-6. PubMed ID: 11229772
[TBL] [Abstract][Full Text] [Related]
13. Contribution of a helix 5 locus to selectivity of hallucinogenic and nonhallucinogenic ligands for the human 5-hydroxytryptamine2A and 5-hydroxytryptamine2C receptors: direct and indirect effects on ligand affinity mediated by the same locus.
Almaula N; Ebersole BJ; Ballesteros JA; Weinstein H; Sealfon SC
Mol Pharmacol; 1996 Jul; 50(1):34-42. PubMed ID: 8700116
[TBL] [Abstract][Full Text] [Related]
14. Novel fused pyrrole heterocyclic ring systems as structure analogs of LE 300: Synthesis and pharmacological evaluation as serotonin 5-HT(2A), dopamine and histamine H(1) receptor ligands.
Rostom SA
Arch Pharm (Weinheim); 2010 Feb; 343(2):73-80. PubMed ID: 20108267
[TBL] [Abstract][Full Text] [Related]
15. Structure-based identification of aporphines with selective 5-HT(2A) receptor-binding activity.
Munusamy V; Yap BK; Buckle MJ; Doughty SW; Chung LY
Chem Biol Drug Des; 2013 Feb; 81(2):250-6. PubMed ID: 23039820
[TBL] [Abstract][Full Text] [Related]
16. Dibenzo[b,f][1,4]oxazepines and dibenzo[b,e]oxepines: Influence of the chlorine substitution pattern on the pharmacology at the H
Naporra F; Gobleder S; Wittmann HJ; Spindler J; Bodensteiner M; Bernhardt G; Hübner H; Gmeiner P; Elz S; Strasser A
Pharmacol Res; 2016 Nov; 113(Pt A):610-625. PubMed ID: 27697645
[TBL] [Abstract][Full Text] [Related]
17. Novel 4-substituted-N,N-dimethyltetrahydronaphthalen-2-amines: synthesis, affinity, and in silico docking studies at serotonin 5-HT2-type and histamine H1 G protein-coupled receptors.
Sakhuja R; Kondabolu K; Córdova-Sintjago T; Travers S; Vincek AS; Kim MS; Abboud KA; Fang L; Sun Z; Canal CE; Booth RG
Bioorg Med Chem; 2015 Apr; 23(7):1588-600. PubMed ID: 25703249
[TBL] [Abstract][Full Text] [Related]
18. Structural determinants for high 5-HT(2A) receptor affinity of spiro[9,10-dihydroanthracene]-9,3(')-pyrrolidine (SpAMDA).
Peddi S; Roth BL; Glennon RA; Westkaemper RB
Bioorg Med Chem Lett; 2004 May; 14(9):2279-83. PubMed ID: 15081025
[TBL] [Abstract][Full Text] [Related]
19. Ring substituted analogues of 5-aminomethyl-10,11-dihydro-dibenzo[a,d]cycloheptene (AMDH): potential modes of binding to the 5-HT(2A) receptor.
Peddi S; Roth BL; Glennon RA; Westkaemper RB
Bioorg Med Chem Lett; 2003 Aug; 13(15):2565-8. PubMed ID: 12852967
[TBL] [Abstract][Full Text] [Related]
20. Molecular interaction of serotonin 5-HT2A receptor residues Phe339(6.51) and Phe340(6.52) with superpotent N-benzyl phenethylamine agonists.
Braden MR; Parrish JC; Naylor JC; Nichols DE
Mol Pharmacol; 2006 Dec; 70(6):1956-64. PubMed ID: 17000863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
